Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma

NCT03502148

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Advanced ENT and Allergy Louisville, Kentucky, United States
  • University of Cincinnati Cancer Institute Cincinnati, Ohio, United States
  • Ben Taub Hospital Houston, Texas, United States
  • Memorial Hermann Hospital Houston, Texas, United States
View Trial Details
Completed

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

NCT02105636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Local Institution - 0001 Atlanta, Georgia, United States
  • Local Institution - 0002 Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT01458392

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Acceleron Investigative Site Aurora, Colorado, United States
  • Acceleron Investigative Site Atlanta, Georgia, United States
  • Acceleron Investigative Site Boston, Massachusetts, United States
  • Acceleron Investigative Site Detroit, Michigan, United States
View Trial Details
Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations
  • The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

NCT01212822

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +35 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer

NCT03162224

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +19 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Orlando, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Indianapolis, Indiana, United States
View all 14 locations
View Trial Details
Completed

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

NCT02268695

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de la Dracénie Draguignan, France
  • Centre Médical de Forcilles Férolles-Attilly, France
  • Clinique des Ormeaux Le Havre, France
View all 17 locations
View Trial Details

Related conditions